Tiny blood samples, big clues: new study tracks brain health in preemies

NCT ID NCT07159555

Recruiting now Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Liege Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at levels of a brain protein called neurofilament in the blood of healthy late preterm babies (born at 34-37 weeks). Researchers want to know what normal levels are and how they change in the first weeks of life. Up to 15 newborns will provide extra blood during routine tests. The goal is to create a reference range that can help doctors better diagnose and treat nerve diseases like spinal muscular atrophy (SMA) in the future.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY PARTICIPANTS

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hopital Citadelle
RECRUITING

Liège, 4000, Belgium

Contact

Contact Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••